Search hospitals > California > Fresno
Kaiser Permanente-Fresno
Claim this profileFresno, California 93720
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Stomach Cancer
150 reported clinical trials
6 medical researchers
Summary
Kaiser Permanente-Fresno is a medical facility located in Fresno, California. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Stomach Cancer and other specialties. Kaiser Permanente-Fresno is involved with conducting 150 clinical trials across 319 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
38 reported clinical trials
103 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara3 years of reported clinical research
Studies Breast Cancer
Studies Prostate Cancer
22 reported clinical trials
63 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo2 years of reported clinical research
Studies Skin Cancer
Studies Cutaneous Melanoma
22 reported clinical trials
52 drugs studied
Natalya Greyz-YusupovKaiser Permanente-Fresno5 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
13 drugs studied
Clinical Trials running at Kaiser Permanente-Fresno
Breast Cancer
Lung Cancer
Skin Cancer
Breast cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Esophageal cancer
Stomach Cancer
Cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-Fresno?
Kaiser Permanente-Fresno is a medical facility located in Fresno, California. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Stomach Cancer and other specialties. Kaiser Permanente-Fresno is involved with conducting 150 clinical trials across 319 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.